Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-17

FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for galantamine hydrobromide submitted by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)

Snippet

SUPPL AP for GALANTAMINE HYDROBROMIDE (GALANTAMINE HYDROBROMIDE)